For people with MS who also have obesity or type 2 diabetes, GLP-1 medications may be worth discussing with a neurologist and primary care provider, though their long-term impact on MS is still unknown
Individualized Approach: Healthcare professionals can tailor treatment plans based on the specific needs and health conditions of each patient.
Its calorically dense, which may offset your diet progress
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial
LAURA: Como dije, es parte de mi rutina ahora
If blood sugar targets are not being met effectively on one medication, the dual action of tirzepatide might provide superior glucose management